Aromatase inhibitors: a useful additional therapeutic option for slowing down advanced bone age in boys with growth hormone deficiency

Mauras N, Ross J, Mericq V (2023) Management of growth disorders in puberty: GH, GnRHa, and aromatase inhibitors: a clinical review. Endocr Rev 44(1):1–13

Article  PubMed  Google Scholar 

Hero M (2016) Aromatase inhibitors in the treatment of short stature. Endocr Dev 30:130–140

Article  CAS  PubMed  Google Scholar 

Linardi A, Damiani D, Longui CA (2017) The use of aromatase inhibitors in boys with short stature: what to know before prescribing? Arch Endocrinol Metab 61(4):391–397

Article  PubMed  PubMed Central  Google Scholar 

Shim KS (2015) Pubertal growth and epiphyseal fusion. Ann Pediatr Endocrinol Metab 20(1):8

Article  PubMed  PubMed Central  Google Scholar 

Barajas-Nava LA, Castilla-Peón MF (2021) Aromatase inhibitors for short stature in male children and adolescents. Bol Med Hosp Infant Mex 78(5):457–460

PubMed  Google Scholar 

Sendur MAN, Aksoy S, Zengin N, Altundag K (2013) Comparative efficacy study of 5-year letrozole or anastrozole in postmenopausal hormone receptor-positive early breast cancer. J BUON 18(4):838–844

CAS  PubMed  Google Scholar 

Ellis MJ, Suman VJ, Hoog J, Lin L, Snider J, Prat A et al (2011) Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based int. J Clin Oncol 29(17):2342–2349

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hero M, Varimo T, Raivio T (2020) Aromatase inhibitors in puberty. Curr Opin Endocr Metab Res 14:37–41

Article  Google Scholar 

Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL et al (2008) Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 93(11):4210–4217

Article  CAS  PubMed  Google Scholar 

Wit JM (2021) Should skeletal maturation be manipulated for extra height gain? Front Endocrinol (Lausanne) 12:1–18

Article  Google Scholar 

Hero M, Norjavaara E, Dunkel L (2005) Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial. J Clin Endocrinol Metab 90(12):6396–6402

Article  CAS  PubMed  Google Scholar 

Ma Y, Jia R, Xia B, Tang B, Xu Z (2022) Adult height in pubertal boys with short stature treated with GH/letrozole: a hospital record-based retrospective study. BMC Pediatr 22(1):1–8

Article  Google Scholar 

Kong Y, Chen H, Liang L, Zheng M, Fang Y, Wang C (2020) Aromatase inhibitors combined with growth hormone in treatment of adolescent boys with short stature. Zhejiang Da Xue Xue Bao Yi Xue Ban 49(3):283–290

PubMed  PubMed Central  Google Scholar 

Pedrosa LF, de Oliveira JM, Thomé PRV, Kochi C, Damiani D, Longui CA (2017) Height increment and laboratory profile of boys treated with aromatase inhibitors with or without growth hormone. Horm Metab Res 49(10):778–785

Article  CAS  PubMed  Google Scholar 

Demir K, Konakçı E, Özkaya G, Kasap Demir B, Özen S, Aydın M et al (2020) New features for child metrics: further growth references and blood pressure calculations. J Clin Res Pediatr Endocrinol 12(2):125–129

Article  PubMed  PubMed Central  Google Scholar 

Neyzi O, Bundak R, Gökçay G, Günöz H, Furman A, Darendeliler F et al (2015) Reference values for weight, height, head circumference, and body mass index in Turkish children. J Clin Res Pediatr Endocrinol 7(4):280–293

Article  PubMed  PubMed Central  Google Scholar 

Tanner JM (1986) 1 Normal growth and techniques of growth assessment. Clin Endocrinol Metab 15(3):411–451

Article  CAS  PubMed  Google Scholar 

Tanner JM, Whitehouse RH (1976) Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51(3):170–179

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd edn. University Press, Stanford, p 185

Google Scholar 

Bayley N, Pinneau SR (1952) Tables for predicting adult height from skeletal age: revised for use with the greulich-pyle hand standards. J Pediatr 40(4):423–441

Article  CAS  PubMed  Google Scholar 

Mauras N, Ross JL, Gagliardi P, Yu YM, Hossain J, Permuy J et al (2016) Randomized trial of aromatase inhibitors, growth hormone, or combination in pubertal boys with idiopathic, short stature. J Clin Endocrinol Metab 101(12):4984–4993

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mauras N, De Pijem LG, Hsiang HY, Desrosiers P, Rapaport R, Schwartz ID et al (2008) Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years. J Clin Endocrinol Metab 93(3):823–831

Article  CAS  PubMed  Google Scholar 

Rothenbuhler A, Linglart A, Bougnères P (2017) Erratum to: a randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature. Int J Pediatr Endocrinol 2017(1):41–44

Article  Google Scholar 

Miller BS, Ross J, Ostrow V (2020) Height outcomes in children with growth hormone deficiency and idiopathic short stature treated concomitantly with growth hormone and aromatase inhibitor therapy: data from the ANSWER program. Int J Pediatr Endocrinol 2020(1):4–9

Article  Google Scholar 

Shams K, Cameo T, Fennoy I, Hassoun AA, Lerner SE, Aranoff GS et al (2014) Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress: a retrospective chart review. J Pediatr Endocrinol Metab 27(7–8):725–730

CAS  PubMed  PubMed Central  Google Scholar 

Ferris JA, Geffner ME (2017) Are aromatase inhibitors in boys with predicted short stature and/or rapidly advancing bone age effective and safe? J Pediatr Endocrinol Metab 30(3):311–317

Article  CAS  PubMed  Google Scholar 

Varimo T, Toiviainen-Salo S, Raivio T, Kerttula L, Dunkel L, Hero M (2019) Letrozole monotherapy in pre- and early-pubertal boys does not increase adult height. Front Endocrinol (Lausanne) 10:6–11

Article  Google Scholar 

Neely EK, Kumar RB, Payne SL, Ranadive SA, Suchet DI (2014) Letrozole vs anastrozole for height augmentation in short pubertal males: first year data. J Clin Endocrinol Metab 99(11):4086–4093

Article  CAS  PubMed  Google Scholar 

Dutta D, Singla R, Surana V, Sharma M (2022) Efficacy and safety of letrozole in the management of constitutional delay in growth and puberty: a systematic review and meta-analysis. J Clin Res Pediatr Endocrinol 14(2):131–144

Article  PubMed  PubMed Central  Google Scholar 

Wickman S, Dunkel L (2001) Inhibition of P450 aromatase enhances gonadotropin secretion in early and midpubertal boys: evidence for a pituitary site of action of endogenous E. J Clin Endocrinol Metab 86(10):4887–4894

Article  CAS  PubMed  Google Scholar 

Comments (0)

No login
gif